Information for "Otlertuzumab (TRU-016)"
Jump to navigation
Jump to search
View the protection log for this page.
Basic information
| Display title | Otlertuzumab (TRU-016) |
| Default sort key | Otlertuzumab (TRU-016) |
| Page length (in bytes) | 2,110 |
| Page ID | 1134 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Jwarner (talk | contribs) |
| Date of page creation | 14:29, 11 December 2014 |
| Latest editor | Warner-admin (talk | contribs) |
| Date of latest edit | 14:04, 4 May 2023 |
| Total number of edits | 22 |
| Total number of distinct authors | 3 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |